pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked ·
1,486
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 2
HPV Induced Cancers
Cervical Cancer
Theravectys SA
0
catalysts
Phase 2
HST-1011
Anal Cancer
HotSpot Therapeutics Inc
0
catalysts
Phase 2
HUNS-001
Cerebral Infarction (Brain Infarction)
Rainbow Inc
0
catalysts
Phase 2
HeXell-2020
Coronary Artery Disease (CAD) (Ischemic Heart Disease)
← prev
page 14 of 50
next →
131
Pain
89
Neurology
1
Hexun Bioscience Co Ltd
0
catalysts
Phase 2
IAE-0972
Cutaneous Squamous Cell Carcinoma (cSCC)
Sunho (China) Biopharmaceutical Co Ltd
0
catalysts
Phase 2
IAP-0971
Cervical Cancer
Sunho (China) Biopharmaceutical Co Ltd
0
catalysts
Phase 2
IBB-0979
Solid Tumor
Sunho (China) Biopharmaceutical Co Ltd
0
catalysts
Phase 2
IBI-363
Metastatic Melanoma
Innovent Biologics Inc
0
catalysts
Phase 2
IC-265
Allergic Conjunctivitis
IACTA Pharmaceuticals Inc
0
catalysts
Phase 2
IC-270
Allergic Conjunctivitis
IACTA Pharmaceuticals Inc
0
catalysts
Phase 2
ICES-13
Stress Urinary Incontinence
Innovacell Co Ltd
0
catalysts
Phase 2
ICT-01
Metastatic Melanoma
ImCheck Therapeutics SAS
0
catalysts
Phase 2
IDE-161
Colon Cancer
$IDYA
IDEAYA Biosciences, Inc.
0
catalysts
Phase 2
IDE-275
Endometrial Cancer
$IDYA
IDEAYA Biosciences, Inc.
0
catalysts
Phase 2
IDE-397
Adenoid Cystic Carcinoma (ACC)
$IDYA
IDEAYA Biosciences, Inc.
0
catalysts
Phase 2
IGV-001
Glioblastoma Multiforme (GBM)
Imvax Inc
0
catalysts
Phase 2
IIV-HD + rC19
Coronavirus Disease 2019 (COVID-19)
$SNY
Sanofi
0
catalysts
Phase 2
IM-101
Myasthenia Gravis
ImmunAbs Inc
0
catalysts
Phase 2
IMA-203CD8
Solid Tumor
Immatics NV
0
catalysts
Phase 2
IMB-101
Hidradenitis Suppurativa
Navigator Medicines Inc
0
catalysts
Phase 2
IMG-007
Atopic Dermatitis (Atopic Eczema)
$IMA
ImageneBio, Inc.
0
catalysts
Phase 2
IMM-124E
Travelan
Traveler's Diarrhea
$IMRN
Immuron Ltd
0
catalysts
Phase 2
IMM01-STEM
Muscle Atrophy
Immunis Inc
0
catalysts
Phase 2
IMNN-101
Coronavirus Disease 2019 (COVID-19)
$IMNN
Imunon, Inc.
0
catalysts
Phase 2
IMP-1734
Fallopian Tube Cancer
$EIKN
Eikon Therapeutics, Inc.
0
catalysts
Phase 2
IMP-9064
Solid Tumor
IMPACT Therapeutics Inc
0
catalysts
Phase 2
IMS-001
Primary Progressive Multiple Sclerosis (PPMS)
Imstem Biotechnology Inc
0
catalysts
Phase 2
IMT-009
Burkitt Lymphoma
Immunitas Therapeutics Inc
0
catalysts
Phase 2
IMU-131
Gastric Cancer
Imugene Ltd
0
catalysts
Phase 2
INKmune
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
$INMB
Inmune Bio, Inc.
0
catalysts
